Arrhythmias in chronic kidney disease

Heart

Volumn 97, Issue 9, 2011, Pages 766-773

  Roberts, Paul R ^a   Green, Darren ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; COTRIMOXAZOLE; CYCLOSPORIN; DIGOXIN; DILTIAZEM; DOMPERIDONE; DRONEDARONE; ENOXAPARIN; ERYTHROMYCIN; FLECAINIDE; LIDOCAINE; MACROLIDE; MIDODRINE; QUININE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SOTALOL; TACROLIMUS; TRIAZOLE DERIVATIVE; VERAPAMIL; WARFARIN;

ARTICLE; BRADYCARDIA; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EXCRETION; DRUG POTENTIATION; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HEMODIALYSIS; HUMAN; HYPERKALEMIA; INCIDENCE; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PRIORITY JOURNAL; QT PROLONGATION; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; HUMANS; KIDNEY TRANSPLANTATION; PACEMAKER, ARTIFICIAL; RENAL INSUFFICIENCY, CHRONIC;

EID: 79953898198     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.208587     Document Type: Article

References (21)

1. US Renal Data System. USRDS 2003 Annual Data Report. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
2. Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrology 2001;12:1516-23. (Pubitemid 32666335)
3. US Renal Data System. USRDS 2008 Annual Data Report. National Institute of Health, National Institute of Diabetes and Digestive and Renal Diseases, 2008.
4. Vazquez E, Sanchez-Perales C, Lozano C, et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 2003;92:868-71. (Pubitemid 37163591)
5. Krane V, Heinrich F, Meesmann M, et al. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol 2009;4:394-400.
6. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 2007;3:853-76.
7. DeLoach SS, Townsend RR. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol 2008;3:184-92.
8. Foley RN, Parfrey PS, Harnett JD, et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995;5:2024-31.
9. Kovesdy C, Regidor D, Mehrotra R, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2007;2:999-1007.
10. Reinecke H, Brand E, Mesters R, et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 2009;20:705-11.
11. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in haemodialysis patients. Ren Fail 2001;23:71-6. (Pubitemid 32207295)
12. Pun PH, Smarz TR, Honeycutt EF, et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009;76:652-8.
13. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999;55:1553-9. (Pubitemid 29157156)
14. Karnik JA, Young BS, Lew NL, et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001;60:350-7. (Pubitemid 32587574)
15. Abbott K, Trespalacios F, Agodoa L, et al. Beta-blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality. Arch Intern Med 2004;164:2465-71. (Pubitemid 39628074)
16. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathdexecutive summary. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006;48:1064-108.
17. Turakhia MP, Varosy PD, Lee K, et al. Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2007;30:377-84. (Pubitemid 46426556)
18. Herzog CA, Li S, Weinhandl E, et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005;68:818-25. (Pubitemid 43323139)
19. Mangrum J, Lin D, Dimarco J, et al. Prognostic value of left ventricular systolic function in renal dialysis patients. Heart Rhythm 2006;3:s154.
20. Teruya TH, Abou-Zamzam AM, Limm W, et al. Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surgery 2003;17:526-9. (Pubitemid 37370374)
21. Messa P, Ponticelli C, Berardinelli L. Coming back to dialysis after kidney transplant failure. Nephrol Dial Transplant 2008;23:2738-42.